Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 97 results for "abbott"

Medtronic to withdraw latest stents from India after price cap
Money Control

Abbott's stent withdrawal plea rejected

NPPA asks company to prove superiority and then fix higher price Business Standard, 2 days ago
[x]  

1,787 images for abbott

DNA, 3 days ago
Reuters, 1 week ago
ESPN, 1 week ago
MSN India, 3 weeks ago
Forbes India, 2 months ago
The Telegraph UK, 2 months ago
The Telegraph UK, 1 month ago
Scottish Daily Express, 2 months ago
India.com, 2 months ago
Zolmax News, 2 months ago
DNA

MNCs pull out of stent race, domestic players unfazed

Healthcare major Abbott withdraws stents citing lack of commercial viability
 DNA5 days ago Abbott decides to withdraw 2 stent types from India  Business Standard1 week ago Abbott's fully absorbable stent under the lens of Indian regulator  Business Standard2 weeks ago Higher heart risk seen with Abbott dissolving stent after two years: study  Reuters1 month ago
[x]  
DNA

Parents lack strength to realise unfulfilled dreams: Abbott Nutrition

According to the dream survey released on Tuesday, 97% of the parents agreed that the improvement in strength will help them to fulfill their dreams and have a better quality life.
 DNA3 days ago
DNA

Next up - South African pacer Kyle Abbott.His base price is Rs 1.5 Cr.Goes Unsold!

Next up - South African pacer Kyle Abbott. His base price is Rs 1.5 Cr. Goes Unsold! Select Live Blog: Live #IPL10 auction: Karn Sharma, T Natarajan win big as franchises shell out crores for domestic talent Live Blog Date: Monday, 20 February 2017 - 2:10pm ...
 DNA2 months ago Next up - Australia's Sean Abbott.His base price is Rs 30 Lakh.Goes unsold!  DNA2 months ago Kyle Abbott has 'no sour grapes' towards CSA  Business Standard2 months ago
Money Control

NPPA's 'suspicion' of drug overpricing upsets industry

These include drugs from some of the leading pharmaceutical companies like Sun Pharma, Cipla, Dr Reddy's, Alembic, Abbott Healthcare, GlaxoSmithKline among others. They have been suspected of selling drugs at a
 Money Today1 month ago Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap  Business Standard2 months ago 634 drugs on NPPA's price ceiling non-compliant list  Money Control2 months ago No proposal to extend price cap to other medical devices, says NPPA chief  Business Standard1 day ago

Buy Abbott India; target of Rs 5380: Centrum

Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 5380 in its research report dated February 06, 2017.
 Money Control2 months ago Abbott India Q3 net up 26 pc at Rs 85.56 cr  Money Control2 months ago Abbott India Q3 net up 26% at Rs 85.56 cr  Money Control2 months ago

CCI warns Karnataka chemists and druggists association

The complaint by Belgaum District Chemists and Druggists Association (BCDA) was filed against KCDA as well as Abbott India, Geno Pharmaceuticals and All India Organisation of Chemists And Druggists (AIOCD).
 DNA1 month ago
Rediff.com

Vapi firm becomes India's first to take on Abbott in biodegradeable stents

Meril Life Sciences is first Indian firm to get nod for bio-resorbable cardiac scaffold
 Business Standard2 months ago Australia matters to India more than ever  Rediff.com2 weeks ago India, Australia commit to deepen defence, security ties  Sify2 weeks ago Australian PM accorded ceremonial welcome  Prokerala2 weeks ago
[x]  
Money Control

Global med-tech firms, India locked in tussle after stent price sting

The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing ...
 Money Control15 hours ago
[x]  
Reuters

Abbott sees Alere as challenging 'fixer-upper' after revised deal

Abbott Laboratories said it was looking to close the recently revised deal to buy Alere Inc in the coming months, calling the diagnostics company "a bit of a fixer-upper". Abbott, which reported first-quarter sales and profit ahead of analysts' estimates on ...
 Reuters1 week ago Abbott agrees to buy Alere at lower price from earlier offer  Reuters2 weeks ago Abbott Laboratories agrees to buy Alere at lower price from earlier offer  Business Standard2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less